Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDGFRA | P16234 | 12/20 | 0.75 |
| ▸ | ABL1 | P00519 | 14/20 | 0.74 |
| ▸ | KIT | P10721 | 10/20 | 0.74 |
| ▸ | BCR | P11274 | 12/20 | 0.73 |
| ▸ | PDGFRB | P09619 | 4/20 | 0.73 |
| ▸ | EGFR | P00533 | 2/20 | 0.73 |
| ▸ | KDR | P35968 | 2/20 | 0.73 |
| ▸ | PLK4 | O00444 | 1/20 | 0.73 |
| ▸ | DDX3X | O00571 | 1/20 | 0.73 |
| ▸ | GAK | O14976 | 1/20 | 0.73 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.73 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.73 |
| ▸ | CA12 | O43570 | 1/20 | 0.73 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.73 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.73 |
| ▸ | CA1 | P00915 | 1/20 | 0.73 |
| ▸ | CA2 | P00918 | 1/20 | 0.73 |
| ▸ | LMNA | P02545 | 1/20 | 0.73 |
| ▸ | ALB | P02768 | 1/20 | 0.73 |
| ▸ | RAF1 | P04049 | 1/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5201739 | 0.94 | PDGFRA (0.65) | PDGFRAABL1KITBCRPDGFRB | |
| SCHEMBL27640742 | 0.91 | PDGFRA (0.64) | PDGFRAABL1KITBCRPDGFRB | |
| SCHEMBL5201838 | 0.88 | PDGFRA (0.55) | PDGFRAABL1KITBCRPDGFRB | |
| SCHEMBL3637790 | 0.86 | PDGFRA (1.00) | PDGFRAABL1KITBCRPDGFRB | |
| SCHEMBL31553098 | 0.85 | ABL1 (0.94) | PDGFRAABL1KITBCRPDGFRB | |
| SCHEMBL14375828 | 0.85 | PDGFRA (0.75) | PDGFRAABL1KITBCRPDGFRB | |
| SCHEMBL723757 | 0.85 | PDGFRA (1.00) | PDGFRAABL1KITBCRPDGFRB | |
| Hydrochloric Acid SCHEMBL4396677 | 0.84 | PDGFRA (0.98) | PDGFRAABL1KITBCRPDGFRB | |
| SCHEMBL3065290 | 0.84 | PDGFRA (0.89) | PDGFRAABL1KITBCRPDGFRB | |
| SCHEMBL805395 | 0.84 | PDGFRA (0.85) | PDGFRAABL1KITBCRPDGFRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080248487-A1 | MODULATION OF PROTEIN FUNCTIONALITIES | FLYNN DANIEL L | 2008-10-09 | — | — | US | disclosed |
| US-20080248548-A1 | MODULATION OF PROTEIN FUNCTIONALITIES | FLYNN DANIEL L | 2008-10-09 | — | — | US | disclosed |
| US-7279576-B2 | Anti-cancer medicaments | DECIPHERA PHARMACEUTICALS, LLC (US) | 2007-10-09 | — | — | US | disclosed |
| US-7279576-B2 | Anti-cancer medicaments | DECIPHERA PHARMACEUTICALS, LLC (US) | 2007-10-09 | — | — | US | disclosed |
| US-7279576-B2 | Anti-cancer medicaments | DECIPHERA PHARMACEUTICALS, LLC (US) | 2007-10-09 | — | — | US | disclosed |
| EP-1590344-A4 | ANTI-CANCER MEDICAMENTS | DECIPHERA PHARMACEUTICALS LLC (US) | 2007-08-29 | — | — | EP | disclosed |
| EP-1590344-A2 | ANTI-CANCER MEDICAMENTS | Deciphera Pharmaceuticals, Inc. (US) | 2005-11-02 | — | — | EP | disclosed |
| US-20040176395-A1 | Anti-cancer medicaments | DECIPHERA PHARMACEUTICALS, LLC | 2004-09-09 | — | — | US | disclosed |
| US-20040171075-A1 | Modulation of protein functionalities | DECIPHERA PHARMACEUTICALS, LLC | 2004-09-02 | — | — | US | disclosed |
| WO-2004060305-A2 | ANTI-CANCER MEDICAMENTS | DECIPHERA PHARMACEUTICALS, LLC (US) | 2004-07-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080248548-A1 | MODULATION OF PROTEIN FUNCTIONALITIES | C1QBP, SERPINA6, HSPBP1 | PDGFRA 3742/4885ABL1 3219/4885KIT 4689/4885 |
| US-20040176395-A1 | Anti-cancer medicaments | ABL1, ABL2, SRC | PDGFRA 565/4885ABL1 1/4885KIT 795/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.